Clinigen Group plc Holding(s) in Company (0566N)
October 20 2016 - 4:51AM
UK Regulatory
TIDMCLIN
RNS Number : 0566N
Clinigen Group plc
20 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Clinigen Group PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------ -----------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -----------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -----------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -----------------------
Other (please
specify):
---------------------------------------------------------- -----------------------
3. Full name of person(s) Wasatch Advisors, Inc.
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ------------------------
5. Date of the transaction October 18, 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ------------------------
6. Date on which issuer October 19, 2016
notified:
----------------------------------------------------------- ------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 3%
----------------------------------------------------------- ------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- -------------- ------------ ------------ ------------ -----------
GB00B89J2419 2,423,357 2,423,357 3,823,357 3,823,357 3.33%
--------------- --------------- -------------- ------------ ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- ---------------- ---------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
3,823,357 3.33%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ------------------------------
Wasatch Advisors, Inc.
13. Additional information: 505 Wakara Way, 3(rd) Floor
Salt Lake City, UT 84108
------------------------------------------------------------- ------------------------------
14. Contact name: Rebekah Gold
Sr. Compliance Administrator
------------------------------------------------------------- ------------------------------
15. Contact telephone number: 801-533-0777
------------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPEEALNKFEF
(END) Dow Jones Newswires
October 20, 2016 04:51 ET (08:51 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2023 to Apr 2024